Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02432482 · ClinicalTrials.gov registry record · NA

A Mobile Intervention to Promote Cessation in HIV-infected Smokers

A NA study of Tobacco Use and HIV-1-infection, sponsored by Montefiore Medical Center.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02432482 is a NA study of Tobacco Use and HIV-1-infection that has completed, run by Montefiore Medical Center. The registered enrollment target is 100 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02432482, a NA study of Tobacco Use and HIV-1-infection, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to adapt an existing web-based tobacco treatment program for HIV-infected smokers into a mobile intervention delivered via smartphone. After the adaptation is completed, the investigators will test the program's efficacy at promoting abstinence in a randomized controlled trial.

Interventions

  • BEHAVIORAL Standard care
  • BEHAVIORAL mobile Positively Smoke Free (mPSF)

Study Locations (1)

New York

  • Montefiore Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-12
Est. Completion 2017-04
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT02432482

The ClinicalTrials.gov registry entry for NCT02432482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (74% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.

NCT02432482 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02432482 about?

NCT02432482 is a clinical study titled "A Mobile Intervention to Promote Cessation in HIV-infected Smokers". The purpose of this study is to adapt an existing web-based tobacco treatment program for HIV-infected smokers into a mobile intervention delivered via smartphone. After the adaptation is completed, the investigators will test the program's efficacy at promoting abstinence in a randomized controlled...

What is the current status of trial NCT02432482?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-12. Estimated completion is 2017-04.

What conditions does trial NCT02432482 study?

This clinical trial studies the following conditions: Tobacco Use, HIV-1-infection.

What interventions are being tested in trial NCT02432482?

The interventions under investigation include: Standard care (BEHAVIORAL), mobile Positively Smoke Free (mPSF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02432482?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02432482 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.